Dr. d'Amato is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2401 S. 31 Street
Temple Texas
Temple, TX 76508Phone+1 254-724-5989
Education & Training
- Allegheny Health Network Medical Education Consortium (AGH)Fellowship, Thoracic Surgery, 1996 - 1999
- Eastern Virginia Medical SchoolResidency, Surgery, 1990 - 1995
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1990
- Binghamton University, State University of New YorkPhD, Biological Sciences, Biochemistry, 1981 - 1986
- Binghamton UniversityPhD, Biology, 1986
- The Pennsylvania State UniversityBS, Microbiology, 1980 - 1984
- The Pennsylvania State University, University Health ServicesBS, Microbiology, 1980
Certifications & Licensure
- CA State Medical License 2001 - 2026
- TX State Medical License 2022 - 2026
- VA State Medical License 2008 - 2026
- NV State Medical License 2017 - 2025
- MT State Medical License 2017 - 2019
- NY State Medical License 2008 - 2019
- OH State Medical License 2009 - 2019
- American Board of Surgery Surgery
- American Board of Thoracic Surgery Thoracic and Cardiac Surgery
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013
- Resident Research Award Allegheny General Hospital, Pittsburgh, Pennsylvania, 1999
- Resident Research Day Paper Competition, American Heart Association, Third Prize, Pittsburgh, Pennsylvania, 1999
- Join now to see all
Clinical Trials
Publications & Presentations
PubMed
- 29 citationsRisk of Pneumonectomy After Induction Therapy for Locally Advanced Non-Small Cell Lung CancerThomas A. d’Amato, Ahmad S. Ashrafi, Matthew J. Schuchert, Derar S.A. Alshehab, Andrew J.E. Seely
The Annals of Thoracic Surgery. 2009-10-01 - 11 citationsSurvival Among Patients with Platinum Resistant, Locally Advanced Non-Small Cell Lung Cancer Treated with Platinum-Based Systemic TherapyThomas A. d’Amato, Brian L. Pettiford, Mathew J. Schuchert, Ricardo J. Parker, William A. Ricketts
Annals of Surgical Oncology. 2009-07-16 - 6 citationsLaparoscopic Clam Shell Partial Fundoplication Achieves Effective Reflux Control With Reduced Postoperative Dysphagia and Gas BloatingAmgad El-Sherif, Prasad S. Adusumilli, Brian L. Pettiford, Thomas A. d’Amato, Matthew J. Schuchert
The Annals of Thoracic Surgery. 2007-11-01
Journal Articles
- Characteristics of a New Bacteriophage, *23-1-a, Infecting Pseudomonas phaseolicola HB10Y.Taylor, William D., DeLuca, Neal, Vollherbst, Kathryn, Doman, Thomas, d'Amato, Thomas A., and Wallace Snipes, Journal of Virology
- Subcellular Localization of Chorismate-Mutase Isoenzymes in Protoplasts from Mesophyll and Suspension-Cultured Cells of Nicotiana silvestris.d'Amato, Thomas A., Ganson, Robert J., Gaines, C. Greg, and Roy A. Jensen, Planta
- Properties of the DAHP (3-DEOXY-D-ARABINO HEPTULOSONATE 7-PHOSPHATE) Synthase Isozyme System in Nicotiana silvestris and Other Higher Plants.Ganson, Robert J., d'Amato, Thomas A., and Roy A. Jensen, Plant Physiology
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Subcellular Localization of Aromatic Amino Acid Biosynthetic Enzymes in Nicotiana silvestris.d'Amato, Thomas A., Goers, Stephen K., Fischer, Randy S., Gaines, C. Greg, Rubin, Judith L., and Roy A. Jensen, Plant Physiology
- Differential Roles of the DAHP (3-DEOXY-D-ARABINO HEPTULOSONATE 7-PHOSPHATE) Synthase Isozyme Pair in Nicotiana silvestris.Ganson, Robert J., d'Amato, Thomas A. and Roy A. Jensen, Plant Physiology
- Does Chloroplast DNA Code for the Aromatic Pathway?d'Amato, Thomas A., and Roy A. Jensen, Eighteenth Adirondacks Molecular Biology and Genetics Conference
- Join now to see all
Lectures
- New Directions in the Management of Marginally Resectable Lung Cancer.San Diego, California
- Marginally Resectable Lung Cancer – Surgical Options.Department of Surgery, University of California San Diego
- Adjuvant chemotherapy and extreme drug resistance testing in lung cancer.Portland, Oregon
- Join now to see all
Professional Memberships
- Member
- Member
- CATHOLIC MEDICAL ASSOCIATIONMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: